Financing instruments for listed issuers

Financing instruments for listed issuers fall into a short list of structures, and they differ on one axis before any other: whether the securities are registered when they are issued or registered afterwards. That single fact sets the resale timeline, the disclosure sequence, the dilution profile, and whether a shareholder vote comes into scope.

Key takeaways

• Registration timing is the first fork. Registered direct offerings and ATM programmes deliver stock a non-affiliate can already sell. Everything else delivers restricted securities.
• Price is set in one of three ways. Fixed at signing, market-referenced to a volume-weighted average over a window, or floating with the market. The third is where the reputational trouble lives.
• Capacity belongs to the exchange. Nasdaq Listing Rule 5635(d) requires shareholder approval for a 20% Issuance priced below the Minimum Price, and registering the securities does not exempt it.
• Certainty and control trade against each other. A PIPE or registered direct gives a known amount on a known date; a facility or ATM gives control of timing but no certainty of size.
• All of it needs an existing float. Every mechanic here prices against a traded market, so a company with no listing and none in progress cannot use any of them.

The master comparison

Nine structures cover almost every equity and equity-linked raise a listed company does outside a firm-commitment underwritten follow-on.

Registration timing decides the resale timeline

Two structures deliver securities that are already registered: the registered direct offering and the at-the-market programme. Both come off an effective registration statement, so a purchaser who is not an affiliate receives stock that can be sold without a further filing. Every other structure delivers restricted securities, which reach the market only on effectiveness of a resale registration statement or after the Rule 144 holding period where Rule 144 is available at all.

The expensive mistake here is assuming that it is. Rule 144 is not available for securities of a current or former shell company except on the conditions in Rule 144(i), which catches much of the reverse-merger population. Where it is unavailable the route out is an resale registration statement, on the SEC's timetable rather than the parties'.

Fixed, market-referenced or floating

A fixed price is agreed at signing and does not move: PIPE transactions, registered direct offerings and most convertible debentures work this way. The issuer knows the share count on day one, and so does the market when the transaction is announced.

A market-referenced price is calculated at each draw from a volume-weighted average price over a short window. Every facility here prices this way, so the issuer controls the reference window by controlling when it draws. That suits predictable liquidity and suits nobody with three thin trading days a week. A floating conversion price resets with the market and has no floor: it is the mechanic behind death spiral financing, worked through on dilution and conversion mechanics.

Capacity: what the exchange lets you issue

Securities law tells an issuer how it may sell. The listing rules tell it how much, and at what price, without asking shareholders first. On Nasdaq, Listing Rule 5635(d) requires shareholder approval before a 20% Issuance priced below the Minimum Price: the lower of the closing price immediately preceding the signing of the binding agreement, or the average closing price for the five trading days immediately preceding that signing. The NYSE applies a comparable test under Section 312.03, NYSE American under Section 713. The rule is set out on this site under the Nasdaq 20% rule.

Registering the securities does not remove the issue. Nasdaq's interpretative material IM-5635-3 treats "public offering" as a facts-and-circumstances question, weighing the type of offering, how it was marketed, how many investors took it and how deep the discount was. A registered offering placed with three funds at a discount can fail that test. Elsewhere the analogue is a capacity limit rather than a price test: see ASX placement capacity, the HKEX general mandate and the other ten markets.

Choosing by constraint

The structure is chosen by whichever constraint binds hardest. If a defined amount has to be in the bank by a date, it is a fixed-price structure: a registered direct offering where a shelf is effective, a PIPE transaction where it is not. If avoiding a negotiated discount matters more than certainty of size, an at-the-market programme sells at market prices but converts to cash only as fast as the order book allows. If the need recurs, a facility is cheaper to administer: start at equity facilities.

And if a discount would cross the Minimum Price test, the choice narrows to pricing at or above it, issuing less, or calling a meeting. Run that test before terms are discussed. Check whether you qualify sets out the float, volume and reporting facts that decide which structures are open. If the binding constraint is already known, send the exchange, the float and the traded value.

Every instrument in detail

• PIPE or registered direct
• Rule 144 explained
• S-3 shelf registration
• Financing US-listed issuers
• Capital raising for listed companies

Primary sources

• Nasdaq Listing Rules — Rule 5635 and IM-5635-3 (shareholder approval and the meaning of "public offering")
• NYSE Listed Company Manual — Section 312.03 (shareholder approval)
• U.S. Securities and Exchange Commission — Form S-3 and its General Instructions
• U.S. Securities and Exchange Commission — Revisions to Rules 144 and 145 (small-entity compliance guide)

Financing instruments: frequently asked questions

Which financing instrument dilutes existing shareholders least?

None of them avoids dilution; they differ in when it lands and how visible it is. An at-the-market programme dilutes at the lowest per-share cost, but only where daily traded volume can absorb the shares. A fixed-price registered direct offering or PIPE transaction dilutes by a known amount on a known date. Facilities and floating-conversion instruments dilute gradually, and the total is not known at signing.

Can a private company use any of these structures?

No. Every structure on this page prices against a public market. A PIPE transaction is by definition an investment in a public company, a registered direct offering needs an effective registration statement, and every facility prices its draws off a traded volume-weighted average price. A company with no listed shares and none in progress has nothing to reference.

What decides whether an issuer can use a registered structure?

In the United States it is Form S-3 eligibility and an effective shelf. An issuer current in its Exchange Act reporting that meets the form requirements can price off a shelf quickly; one that cannot must register on Form S-1, which takes SEC review, or sell unregistered securities and register the resale afterwards. Elsewhere the equivalent question is whether a base prospectus or a standing issuance authority is already in place.

Do these structures require shareholder approval?

Sometimes, and the test is set by the exchange rather than the securities regulator. On Nasdaq, shareholder approval is required before a 20% Issuance priced below the Minimum Price under Listing Rule 5635(d), and the NYSE and NYSE American apply comparable tests. Registering the securities does not switch the rule off. Other venues run their own capacity limits.

How long does each structure take to close?

Timing depends on counsel, the transfer agent, the exchange and the regulator, so no schedule can be promised. As a rough ordering, a registered direct offering off an effective shelf reaches cash fastest, a PIPE transaction follows once documents are agreed, convertible instruments take longer because the terms are more negotiated, and facilities take longest to arrange but are then available on notice.